Fundz

Carta Healthcare Secures $20 Million Series B Funding To Help Additional Health Systems Improve Patient Care Amid Challenging Global Economy, Pandemic Turbulence, And Downturn In Vc Funding

PRIVATENov 02, 2022

Amount Raised

$20 Million

Round Type

Series B

San FranciscoBiotechnologyHealth CareArtificial IntelligenceMedicalMachine LearningHealth Diagnostics

Description

Carta Healthcare®, a pioneer in harnessing the power of clinical data, today announced it closed a $20 million series B round. Investors include Paramark Ventures, Frist Cressey Ventures, American College of Cardiology, Asset Management Ventures, CU Healthcare Innovation Fund, Mass General Brigham, Maverick Ventures Investment Fund, and Storm Ventures.

Who else raised in Medical and Health Diagnostics around the same time

Companies in the same sectors as Carta Healthcare that raised within 45 days of this round, from Fundz verified event records.

  • Optellum raised $14M (Series A) on September 27, 2022.
  • In-Med Prognostics raised $2.1M (Seed) on December 12, 2022.
  • BIODESIX INC raised an undisclosed amount (Debt Financing) on November 16, 2022.
  • Ibex Medical Analytics raised $10M (Funding Round) on November 9, 2022.
  • Incepto raised $27M (Funding Round) on September 19, 2022.
  • RegASK raised $10M (Series A) on December 15, 2022.

Who to call at Carta Healthcare, and when

A new round usually means Carta Healthcare is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Carta Healthcare raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Carta Healthcare, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Carta Healthcare. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Carta Healthcare

Location

San Francisco, California, United States

About

At Carta Healthcare, we believe high-quality data is essential to improving healthcare. Current methods to abstract data for clinical registries are labor-intensive, time-consuming, and costly. By combining artificial intelligence (AI) technology with skilled expert abstractors, Carta Healthcare helps you abstract data faster, more efficiently, at a lower cost, while delivering the highest quality data.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Carta Healthcare raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

4 contacts
Predictive Intelligence
Strategic

ML-powered predictions for Carta Healthcare's next move

See what Strategic adds

Funding Insights

What this usually means
Timeline to next round
Series B companies typically work for 15-20 months before raising new capital
Growth expectations
Series B companies are expected to scale rapidly and expand market reach

Carta Healthcare raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.